TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. BLOOD CULTURE TEST MARKET, BY METHOD
6.1. Overview
6.2. Conventional
6.3. Automated
7. BLOOD CULTURE TEST MARKET, BY PRODUCT
7.1. Overview
7.2. Consumables
7.3. Instruments
8. BLOOD CULTURE TEST MARKET, BY TECHNOLOGY
8.1. Overview
8.2. Culture
8.3. Molecular
8.4. Proteomics
9. BLOOD CULTURE TEST MARKET, BY APPLICATION
9.1. Overview
9.2. Bacteremia
9.3. Fungemia
10. BLOOD CULTURE TEST MARKET, BY END USER
10.1. Overview
10.2. Hospitals
10.3. Reference Labs
11. BLOOD CULTURE TEST MARKET, BY REGION
11.1. Overview
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. France
11.2.3. UK
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Australia
11.3.6. Rest of Asia-Pacific
11.4. Rest of the World
11.4.1. Middle East
11.4.2. Africa
11.4.3. Latin America
12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market Share Analysis
12.4. Major Growth Strategy in the Blood culture test Market,
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Blood culture test Market,
12.7. Key developments and Growth Strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales & Operating Income, 2022
12.8.2. Major Players R&D Expenditure. 2022
13. COMPANY PROFILES
13.1. BD (U.S.)
13.1.1. Company Overview
13.1.2. Financial Overview
13.1.3. Products Offered
13.1.4. Key Developments
13.1.5. SWOT Analysis
13.1.6. Key Strategies
13.2. Abbott Laboratories (U.S.)
13.2.1. Company Overview
13.2.2. Financial Overview
13.2.3. Products Offered
13.2.4. Key Developments
13.2.5. SWOT Analysis
13.2.6. Key Strategies
13.3. F. Hoffmann-La Roche Ltd (Switzerland)
13.3.1. Company Overview
13.3.2. Financial Overview
13.3.3. Products Offered
13.3.4. Key Developments
13.3.5. SWOT Analysis
13.3.6. Key Strategies
13.4. Novartis AG (Switzerland)
13.4.1. Company Overview
13.4.2. Financial Overview
13.4.3. Products Offered
13.4.4. Key Developments
13.4.5. SWOT Analysis
13.4.6. Key Strategies
13.5. Eli Lilly and Company (U.S.)
13.5.1. Company Overview
13.5.2. Financial Overview
13.5.3. Products Offered
13.5.4. Key Developments
13.5.5. SWOT Analysis
13.5.6. Key Strategies
13.6. Terumo Corporation (Japan)
13.6.1. Company Overview
13.6.2. Financial Overview
13.6.3. Products Offered
13.6.4. Key Developments
13.6.5. SWOT Analysis
13.6.6. Key Strategies
13.7. Bruker Corporation (U.S.)
13.7.1. Company Overview
13.7.2. Financial Overview
13.7.3. Products Offered
13.7.4. Key Developments
13.7.5. SWOT Analysis
13.7.6. Key Strategies
13.8. BIOMÉRIEUX SA (FRANCE)
13.8.1. Company Overview
13.8.2. Financial Overview
13.8.3. Products Offered
13.8.4. Key Developments
13.8.5. SWOT Analysis
13.8.6. Key Strategies
13.9. Bayer AG (Germany)
13.9.1. Company Overview
13.9.2. Financial Overview
13.9.3. Products Offered
13.9.4. Key Developments
13.9.5. SWOT Analysis
13.9.6. Key Strategies
13.10. Merck & Co., Inc. (U.S.)
13.10.1. Company Overview
13.10.2. Financial Overview
13.10.3. Products Offered
13.10.4. Key Developments
13.10.5. SWOT Analysis
13.10.6. Key Strategies
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1 BLOOD CULTURE TEST MARKET, SYNOPSIS, 2018-2032
TABLE 2 BLOOD CULTURE TEST MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 4 BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 5 BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 6 BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 11 NORTH AMERICA: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 12 NORTH AMERICA: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 13 US: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 14 US: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 15 US: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 16 US: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 17 US: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 18 CANADA: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 19 CANADA: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 20 CANADA: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 21 CANADA: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 22 CANADA: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 3 EUROPE: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 4 EUROPE: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 EUROPE: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 6 GERMANY: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 7 GERMANY: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 8 GERMANY: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 9 GERMANY: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 10 GERMANY: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 11 FRANCE: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 12 FRANCE: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 13 FRANCE: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 14 FRANCE: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 FRANCE: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 16 ITALY: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 17 ITALY: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 18 ITALY: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 19 ITALY: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 20 ITALY: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 21 SPAIN: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 22 SPAIN: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 23 SPAIN: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 24 SPAIN: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 25 SPAIN: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 26 UK: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 27 UK: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 28 UK: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 29 UK: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 30 UK: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 31 REST OF EUROPE: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 32 REST OF EUROPE: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 33 REST OF EUROPE: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 34 REST OF EUROPE: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 REST OF EUROPE: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 36 ASIA-PACIFIC: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 37 ASIA-PACIFIC: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 38 ASIA-PACIFIC: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 39 ASIA-PACIFIC: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 40 ASIA-PACIFIC: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 41 JAPAN: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 42 JAPAN: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 43 JAPAN: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 44 JAPAN: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 45 JAPAN: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 46 CHINA: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 47 CHINA: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 48 CHINA: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 49 CHINA: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 50 CHINA: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 51 INDIA: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 52 INDIA: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 53 INDIA: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 54 INDIA: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 55 INDIA: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 56 AUSTRALIA: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 57 AUSTRALIA: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 58 AUSTRALIA: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 59 AUSTRALIA: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 60 AUSTRALIA: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 61 SOUTH KOREA: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 62 SOUTH KOREA: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 63 SOUTH KOREA: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 64 SOUTH KOREA: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 65 SOUTH KOREA: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 66 REST OF ASIA-PACIFIC: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 67 REST OF ASIA-PACIFIC: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 68 REST OF ASIA-PACIFIC: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 69 REST OF ASIA-PACIFIC: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 70 REST OF ASIA-PACIFIC: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 71 REST OF THE WORLD: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 72 REST OF THE WORLD: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 73 REST OF THE WORLD: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 74 REST OF THE WORLD: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 75 REST OF THE WORLD: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 76 MIDDLE EAST: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 77 MIDDLE EAST: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 78 MIDDLE EAST: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 79 MIDDLE EAST: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 80 MIDDLE EAST: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 81 AFRICA: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 82 AFRICA: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 83 AFRICA: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 84 AFRICA: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 85 AFRICA: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 86 LATIN AMERICA: BLOOD CULTURE TEST MARKET, BY METHOD, 2018-2032 (USD BILLION)
TABLE 87 LATIN AMERICA: BLOOD CULTURE TEST MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 88 LATIN AMERICA: BLOOD CULTURE TEST MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 89 LATIN AMERICA: BLOOD CULTURE TEST MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 90 LATIN AMERICA: BLOOD CULTURE TEST MARKET, BY END USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE BLOOD CULTURE TEST MARKET
FIGURE 3 MARKET DYNAMICS FOR THE BLOOD CULTURE TEST MARKET
FIGURE 4 BLOOD CULTURE TEST MARKET, SHARE (%), BY METHOD, 2022
FIGURE 5 BLOOD CULTURE TEST MARKET, SHARE (%), BY PRODUCT, 2022
FIGURE 6 BLOOD CULTURE TEST MARKET, SHARE (%), BY TECHNOLOGY, 2022
FIGURE 7 BLOOD CULTURE TEST MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 8 BLOOD CULTURE TEST MARKET, SHARE (%), BY END USER, 2022
FIGURE 9 BLOOD CULTURE TEST MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 NORTH AMERICA: BLOOD CULTURE TEST MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 EUROPE: BLOOD CULTURE TEST MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 ASIA-PACIFIC: BLOOD CULTURE TEST MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 REST OF THE WORLD: BLOOD CULTURE TEST MARKET, SHARE (%), BY REGION, 2022
FIGURE 14 BLOOD CULTURE TEST MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 15 BD (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 BD (U.S.): SWOT ANALYSIS
FIGURE 17 ABBOTT LABORATORIES (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 ABBOTT LABORATORIES (U.S.): SWOT ANALYSIS
FIGURE 19 F. HOFFMANN-LA ROCHE LTD (SWITZERLAND): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 F. HOFFMANN-LA ROCHE LTD (SWITZERLAND): SWOT ANALYSIS
FIGURE 21 NOVARTIS AG (SWITZERLAND): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 NOVARTIS AG (SWITZERLAND): SWOT ANALYSIS
FIGURE 23 ELI LILLY AND COMPANY (U.S.).: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 ELI LILLY AND COMPANY (U.S.).: SWOT ANALYSIS
FIGURE 25 TERUMO CORPORATION (JAPAN): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 TERUMO CORPORATION (JAPAN): SWOT ANALYSIS
FIGURE 27 BRUKER CORPORATION (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 BRUKER CORPORATION (U.S.): SWOT ANALYSIS
FIGURE 29 BIOMÉRIEUX SA (FRANCE): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 BIOMÉRIEUX SA (FRANCE): SWOT ANALYSIS
FIGURE 31 BAYER AG (GERMANY): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 BAYER AG (GERMANY): SWOT ANALYSIS
FIGURE 33 MERCK & CO., INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 MERCK & CO., INC. (U.S.): SWOT ANALYSIS